Hydrogen sulfide ameliorates high glucose-induced pro-inflammation factors in HT-22 cells: Involvement of SIRT1-mTOR/NF-κB signaling pathway

Xinrui Li,Peiquan Yu,Yinghua Yu,Ting Xu,Jiao Liu,Yuan Cheng,Xia Yang,Xiaoying Cui,Cui Yin,Yi Liu
DOI: https://doi.org/10.1016/j.intimp.2021.107545
IF: 5.714
2021-06-01
International Immunopharmacology
Abstract:<p>Hyperglycemia-induced neuroinflammation promotes the progression of diabetic encephalopathy. Hydrogen sulfide (H<sub>2</sub>S) exerts anti-inflammatory and neuroprotective activities against neurodegenerative diseases. However, the effects of H<sub>2</sub>S on hyperglycemia-induced neuroinflammation has not been investigated in neurons. Herein, by using HT-22 neuronal cells, we found that high glucose decreased the levels of endogenous H<sub>2</sub>S and its catalytic enzyme, cystathionine-β-synthase (CBS). The administration of sodium hydrosulfide (NaHS, a H<sub>2</sub>S donor) or S-adenosylmethionine (SAMe, an allosteric activator of CBS) restored high glucose-induced downregulation of CBS and H<sub>2</sub>S levels. Importantly, H<sub>2</sub>S ameliorated high glucose-induced inflammation in HT-22 cells, evidenced by NaHS or SAMe inhibited the pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) expression in HT-22 cells exposed to high glucose. Furthermore, NaHS or SAMe restored the SIRT1 level and the phosphorylation of mTOR and NF-κB p65 disturbed by high glucose in HT-22 cells, suggesting H<sub>2</sub>S reversed high glucose-induced alteration of SIRT1-mTOR/NF-κB signaling pathway. Our results demonstrated that exogenous H<sub>2</sub>S treatment or enhancing endogenous H<sub>2</sub>S synthesis prevents the inflammatory processes in the neurons with the exposure of high glucose. Therefore, increasing the H<sub>2</sub>S level using NaHS or SAMe might shed light on the prophylactic treatment of diabetic encephalopathy.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?